Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.

Diana FerraroP IaffaldanoT GuerraM IngleseM CapobiancoV Brescia MorraM ZaffaroniM MirabellaG LusF PattiP CavallaM CellerinoS MalucchiE PisanoF VitettaD PaolicelliP SolaM Trojanonull null

Published in: Journal of neurology (2021)

The risk of relapses increases with the washout duration when switching from FTY to lymphocyte-depleting agents.

Keyphrases

multiple sclerosis
white matter
single cell
cell therapy
peripheral blood
bone marrow